Gary Lyman, MD, MPH, professor of medicine (Medical Oncology), on camera at the San Antonio Breast Cancer Symposium in December talking about the BOLERO-2 trial as a potentially practice-changing development in the field of breast cancer. He added that more agents are needed for the treatment of advanced metastatic disease.